A 40-year-old volunteer, who was part of the third phase of clinical trial of the coronavirus vaccine being developed by AstraZeneca and Serum Institute of India and is undergoing trials in India, has claimed he suffered neurological symptoms following the dosage. However, the SII on Sunday rejected the charges. Watch the report.